Journal Home
Search for

Volume 91, Issue 1, Pages 46-50 (January 2009)


View previous. 9 of 58 View next.

Measurable serum markers of oxidative stress response in women with endometriosis

Irene V. Lambrinoudaki, M.D.aCorresponding Author Informationemail address, Areti Augoulea, M.D.a, George E. Christodoulakos, M.D.a, Emmanuel V. Economou, Ph.D., F.E.S.C.b, George Kaparos, Ph.D.b, Antonios Kontoravdis, M.D.a, Constantinos Papadias, M.D.a, George Creatsas, M.D., F.A.C.S.a

Received 2 October 2007; received in revised form 6 November 2007; accepted 12 November 2007. published online 18 January 2008.

Objective

To evaluate the hypothesis of increased systemic oxidative stress in patients with endometriosis.

Setting

Tertiary care university hospital.

Design

Cross-sectional study.

Patient(s)

Sixty-six women of reproductive age undergoing laparoscopy.

Intervention(s)

All women were investigated for endometriotic foci during laparoscopy. Forty-five women had laparoscopically and histologically confirmed endometriosis, and 21 women did not have endometriosis.

Main Outcome Measure(s)

Four markers of oxidative stress were assessed in the serum of each patient: heat shock protein 70 (HSP70), HSP70b′, thioredoxin (TRX), and ischemia-modified albumin (IMA).

Result(s)

Mean serum HSP 70b′ level was higher in patients with endometriosis compared with controls (0.178 ng/mL, SD 0.103, and 0.135 ng/mL, SD 0.014, respectively). The disease stage did not affect HSP70b′ levels. Heat shock protein 70, IMA, and TRX levels did not differ between patients with endometriosis and controls. Women with a history of arterial hypertension had higher mean IMA levels compared with women with normal blood pressure independently of the presence of endometriosis (106.7 [SD 25.4] U/mL and 85.0 [SD 11.5] U/mL, respectively).

Conclusion(s)

Endometriosis is associated with increased systemic oxidative stress. The implication of increased systemic oxidative stress in disease progression or the association with other oxidative stress–related pathologic conditions needs to be addressed in further studies.

a Second Department of Obstetrics and Gynecology, University of Athens, Aretaieio Hospital, Athens, Greece

b Hormonal and Biochemical Laboratory, University of Athens, Aretaieio Hospital, Athens, Greece

Corresponding Author InformationReprint requests: Irene Lambrinoudaki, M.D., 27, Themistokleous Street, GR-14578, Dionysos, Athens, Greece (FAX: 0030-210-6410325).

PII: S0015-0282(07)04086-1

doi:10.1016/j.fertnstert.2007.11.021


View previous. 9 of 58 View next.